NCT06960980 Improving ADHD Teen Driving - Virtual Reality
| NCT ID | NCT06960980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Condition | Attention Deficit Hyperactivity Disorder (ADHD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 204 participants |
| Start Date | 2025-09-11 |
| Primary Completion | 2029-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 204 participants in total. It began in 2025-09-11 with a primary completion date of 2029-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Teens with Attention-Deficit/Hyperactivity Disorder (ADHD) have high rates of negative driving outcomes, including motor vehicle crashes, which may be caused by visual inattention (i.e., looking away from the roadway to perform secondary tasks). Two versions of a driving intervention that trains teens to reduce instances of looking away from the roadway will be tested in teens with ADHD.
Eligibility Criteria
Inclusion Criteria: 1. Aged 16-19. 2. Teens will meet DSM ADHD criteria for ADHD-Predominantly Inattentive Presentation or ADHD-Combined Presentation based on the K-SADS interview. 3. Possess a valid driver's license and regularly spend at least 3 hours per week engaged in unsupervised driving. 4. IQ ≥80 as measured by the Kauffman Brief Intelligence Scale - Second Edition (KBIT-2). 5. Parent willing to participate. Exclusion Criteria: 1. On ADHD medication that cannot be washed out on assessment days. 2. Drug or alcohol dependence based on self-report on the Simple Screening Instrument for Alcohol and Other Drugs survey. 3. On psychotropic or neuroleptic medications. 4. At-risk for motion sickness in the driving simulator or in virtual reality. 5. History of moderate to severe head trauma, neurological disorder, or any other organic disorder that could possibly affect brain function. 6. Cannot see the secondary task stimuli without the use of glasses (contacts acceptable).
Contact & Investigator
Jeff N Epstein, Ph.D.
PRINCIPAL INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Frequently Asked Questions
Who can join the NCT06960980 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 19 Years, studying Attention Deficit Hyperactivity Disorder (ADHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06960980 currently recruiting?
Yes, NCT06960980 is actively recruiting participants. Contact the research team at ADHDdriving@cchmc.org for enrollment information.
Where is the NCT06960980 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT06960980 clinical trial?
NCT06960980 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Jeff N Epstein, Ph.D. at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 204 participants.